Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide/cyclic GMP relaxing pathway in the human umbilical vein.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
04 2020
Historique:
received: 30 04 2019
revised: 18 02 2020
accepted: 19 02 2020
entrez: 7 4 2020
pubmed: 7 4 2020
medline: 10 4 2021
Statut: ppublish

Résumé

Intrauterine growth restriction (IUGR) is a leading cause of perinatal mortality and morbidity, and is linked to an increased risk to develop chronic diseases in adulthood. We previously demonstrated that IUGR is associated, in female neonates, with a decreased nitric oxide (NO)-induced relaxation of the umbilical vein (UV). The present study aimed to investigate the contribution of the smooth muscle components of the NO/cyclic GMP (cGMP) pathway to this alteration. UVs were collected in growth-restricted or appropriate for gestational age (AGA) human term newborns. Soluble guanylyl cyclase (sGC) and cGMP-dependent protein kinase (PKG) were studied by Western blot, cGMP production by ELISA and cyclic nucleotide phosphodiesterases (PDEs) activity using a colorimetric assay. Contribution of PDEs was evaluated using the non-specific PDEs inhibitor 3-isobutyl-1-methylxanthine (IBMX) in isolated vessel tension studies. NO-induced relaxation was reduced in IUGR females despite increased sGC protein and activity, and some increase in PKG protein compared to AGA. In males, no significant difference was observed between both groups. In the presence of IBMX, NO-stimulated cGMP production was significantly higher in IUGR than AGA females. Pre-incubation with IBMX significantly improved NO-induced relaxation in all groups and abolished the difference between IUGR and AGA females. IUGR is associated with sex-specific alterations in the UV's smooth muscle. The impaired NO-induced relaxation observed in growth-restricted females is linked to an imbalance in the NO/cGMP pathway. The beneficial effects of IBMX suggest that PDEs are implicated in such alteration and they could represent promising targets for therapeutic intervention.

Identifiants

pubmed: 32250743
pii: S0143-4004(20)30062-X
doi: 10.1016/j.placenta.2020.02.014
pii:
doi:

Substances chimiques

Nitric Oxide 31C4KY9ESH
Cyclic GMP-Dependent Protein Kinases EC 2.7.11.12
Soluble Guanylyl Cyclase EC 4.6.1.2
Cyclic GMP H2D2X058MU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-93

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there is no conflict of interests regarding the publication of this manuscript.

Auteurs

Manon Beaumann (M)

Neonatal Research Laboratory, Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Manon.Beaumann@chuv.ch.

Flavien Delhaes (F)

Neonatal Research Laboratory, Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: fdelhaes@uwo.ca.

Steeve Menétrey (S)

Neonatal Research Laboratory, Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Steeve.Menetrey@chuv.ch.

Sébastien Joye (S)

Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Sebastien.Joye@chuv.ch.

Yvan Vial (Y)

Clinic of Gynecology and Obstetrics, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Yvan.Vial@chuv.ch.

David Baud (D)

Clinic of Gynecology and Obstetrics, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: David.Baud@chuv.ch.

Jacquier Goetschmann Magaly (JG)

Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: magaly.goetschmann@gmail.com.

Jean-François Tolsa (JF)

Neonatal Research Laboratory, Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland; Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Jean-Francois.Tolsa@chuv.ch.

Anne-Christine Peyter (AC)

Neonatal Research Laboratory, Clinic of Neonatology, Department Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011, Lausanne, Switzerland. Electronic address: Anne-Christine.Peyter@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH